Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma
Details
Age
Child
Locations
Childrens Hospital Colorado
Principal Investigator
Holly Lindsay
Study ID
Protocol Number: 23-2339
More information available at ClinicalTrials.gov: NCT05233397
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers